Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Apr;52(4):377–379. doi: 10.1136/thx.52.4.377

Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis

A Schnabel, C Richter, S Bauerfeind, W L Gross
PMCID: PMC1758545  PMID: 9196524

Abstract

BACKGROUND: Pneumonitis is a rare but potentially life threatening side effect of methotrexate treatment for rheumatoid arthritis which needs to be distinguished from interstitial lung disease due to rheumatoid arthritis. METHODS: To examine the value of bronchoalveolar lavage (BAL) in diagnosing methotrexate pneumonitis, the BAL cell profile of four patients with methotrexate pneumonitis was compared with findings in 16 patients with rheumatoid arthritis treated with methotrexate without clinical or radiological evidence of lung disease and eight patients with interstitial lung disease secondary to rheumatoid arthritis treated with methotrexate. RESULTS: Methotrexate pneumonitis was associated with an increase in the lymphocytes in the BAL fluid to 33-68% of total BAL cells. BAL lymphocytosis was also found in five patients in each of the two control groups. The four patients with methotrexate pneumonitis had a disproportionate increase in CD4+ cells to 72-84% of total lymphocytes and in the CD4/CD8 ratio to 17.0, 6.6, 8.7, and 4.0, respectively, figures which exceeded those of the two control groups. CONCLUSIONS: Methotrexate pneumonitis was associated with lymphocytic alveolitis with a preferential increase in CD4+ cells. This pattern differs from that in interstitial lung disease due to rheumatoid arthritis and may therefore assist in making an early diagnosis of methotrexate pneumonitis. 




Full Text

The Full Text of this article is available as a PDF (116.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoun G. M., Mayaud C. M., Touboul J. L., Denis M. F., Milleron B. J., Perrot J. Y. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax. 1987 Sep;42(9):652–655. doi: 10.1136/thx.42.9.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anaya J. M., Diethelm L., Ortiz L. A., Gutierrez M., Citera G., Welsh R. A., Espinoza L. R. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum. 1995 Feb;24(4):242–254. doi: 10.1016/s0049-0172(95)80034-4. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. F., Grisso C. L., Abrams J. S., Band H., Rea T. H., Modlin R. L. Gamma delta T lymphocytes in human tuberculosis. J Infect Dis. 1992 Mar;165(3):506–512. doi: 10.1093/infdis/165.3.506. [DOI] [PubMed] [Google Scholar]
  4. Barrera P., Laan R. F., van Riel P. L., Dekhuijzen P. N., Boerbooms A. M., van de Putte L. B. Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis. 1994 Jul;53(7):434–439. doi: 10.1136/ard.53.7.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carson C. W., Cannon G. W., Egger M. J., Ward J. R., Clegg D. O. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum. 1987 Feb;16(3):186–195. doi: 10.1016/0049-0172(87)90021-7. [DOI] [PubMed] [Google Scholar]
  6. Garcia J. G., Parhami N., Killam D., Garcia P. L., Keogh B. A. Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis. 1986 Mar;133(3):450–454. doi: 10.1164/arrd.1986.133.3.450. [DOI] [PubMed] [Google Scholar]
  7. Pourel J., Guillemin F., Fener P., Webanck L., Bene M. C., Delorme N. Delayed methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol. 1991 Feb;18(2):303–304. [PubMed] [Google Scholar]
  8. Scherak O., Popp W., Kolarz G., Wottawa A., Ritschka L., Braun O. Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs. J Rheumatol. 1993 Jun;20(6):944–949. [PubMed] [Google Scholar]
  9. Schnabel A., Dalhoff K., Bauerfeind S., Barth J., Gross W. L. Sustained cough in methotrexate therapy for rheumatoid arthritis. Clin Rheumatol. 1996 May;15(3):277–282. doi: 10.1007/BF02229707. [DOI] [PubMed] [Google Scholar]
  10. Tazi A., Bouchonnet F., Valeyre D., Cadranel J., Battesti J. P., Hance A. J. Characterization of gamma/delta T-lymphocytes in the peripheral blood of patients with active tuberculosis. A comparison with normal subjects and patients with sarcoidosis. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1216–1221. doi: 10.1164/ajrccm/146.5_Pt_1.1216. [DOI] [PubMed] [Google Scholar]
  11. Ueta C., Tsuyuguchi I., Kawasumi H., Takashima T., Toba H., Kishimoto S. Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun. 1994 Dec;62(12):5434–5441. doi: 10.1128/iai.62.12.5434-5441.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. White D. A., Rankin J. A., Stover D. E., Gellene R. A., Gupta S. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis. 1989 Jan;139(1):18–21. doi: 10.1164/ajrccm/139.1.18. [DOI] [PubMed] [Google Scholar]
  13. Yousem S. A., Colby T. V., Carrington C. B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis. 1985 May;131(5):770–777. doi: 10.1164/arrd.1985.131.5.770. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES